Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korean Govt Rejects Industry Call For Price Cut Delay

This article was originally published in PharmAsia News

Executive Summary

The South Korean government has decided to push ahead with a drug price cut slated for early 2016 after reviewing the pharma industry's call to postpone the cut by one year. Based on an expert analysis it has conducted, the government concluded that the outbreak of Middle East Respiratory Syndrome (MERS) in the country earlier this year did not have a large impact on pharma firms' revenues.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts